Increased in vitro activity of ceftriaxone by addition of tazobactam against clinical isolates of anaerobes
- 31 August 1994
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 19 (4) , 227-234
- https://doi.org/10.1016/0732-8893(94)90036-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteriaEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Antianaerobic activity of various antimicrobial agents against beta-lactamase-positive and -negative strains of the Bacteroides fragilis groupCurrent Therapeutic Research, 1992
- Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)Diagnostic Microbiology and Infectious Disease, 1989
- Mechanisms of resistance in anaerobes and new developments in testingDiagnostic Microbiology and Infectious Disease, 1989
- Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactamAntimicrobial Agents and Chemotherapy, 1988
- Beta-lactamase-mediated imipenem resistance in Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1986
- Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamasesAntimicrobial Agents and Chemotherapy, 1986
- Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1986
- Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillinAntimicrobial Agents and Chemotherapy, 1984
- Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase productionJournal of Medical Microbiology, 1983